Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14426 - 14450 of 15379 in total
JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment of narcolepsy.
Investigational
Matched Description: … JNJ-17216498 is a histamine receptor H3 antagonist developed by Johnson and Johnson for the treatment …
Experimental
Investigational
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Displaying drugs 14426 - 14450 of 15379 in total